Status:
COMPLETED
Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Arterial Occlusive Diseases
Atherosclerosis
Eligibility:
All Genders
Brief Summary
The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in pati...
Detailed Description
The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in pati...
Eligibility Criteria
Patients who are being evaluated to determine if they have CAD or those who have already been studied and the presence or absence of CAD has been ascertained.
No patients who have not been evaluated for CAD.
Key Trial Info
Start Date :
June 1 1996
Trial Type :
OBSERVATIONAL
End Date :
September 1 2000
Estimated Enrollment :
355 Patients enrolled
Trial Details
Trial ID
NCT00001531
Start Date
June 1 1996
End Date
September 1 2000
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892